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Abstract: Chromium is a widespread industrial waste. The soluble hexavalent chromium Cr 
(VI) is an environmental contaminant widely recognized to act as a carcinogen, mutagen 
and teratogen towards humans and animals. The fate of chromium in the environment is 
dependent on its oxidation state. Hexavalent chromium primarily enters the cells and 
undergoes metabolic reduction to trivalent chromium, resulting in the formation of reactive 
oxygen species together with oxidative tissue damage and a cascade of cellular events. 
However, the results from in vitro studies are often conflicting. The aim of this study was to 
develop a model to establish relationships between cytotoxicity, genotoxicity and oxidative 
stress, in human liver carcinoma [HepG2] cells exposed to potassium dichromate. HepG2 
cells were cultured following standard protocols and exposed to various concentrations [0-
50 µM] of potassium dichromate [K2Cr2O7]. Following exposure to the toxic metal, the 
MTT assay was performed to assess the cytotoxicity, the thiobarbituric acid test to evaluate 
the degree of lipid peroxidation as an indicator of oxidative stress and the alkaline comet 
assay was used to assess DNA damage to study genotoxicity. The results of the study 
indicated that potassium dichromate was cytotoxic to HepG2 cells. The LD50 values of 8.83 
± 0.89 µg/ml, 6.76 ± 0.99 µg/ml, respectively, for cell mortality at 24 and 48 hrs were 
observed, indicating a dose- and time-dependent response with regard to the cytotoxic 
effects of potassium dichromate. A statistically significant increase in the concentration of 
malondialdehyde [MDA], an indicator of lipid peroxidation, was recorded in exposed cells 
[15.9 – 69.9 µM] compared to control [13 µM]. Similarly, a strong dose-response 
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relationship (p<0.05) was also obtained with respect to potassium dichromate induced DNA 
damage (comet assay) in HepG2 cells exposed [3.16 ± 0.70 – 24.84 ± 1.86 microns – mean 
comet tail length]; [12.4 ± 1.45% – 76 ± 1.49% – % tail DNA] to potassium dichromate than 
control [3.07 ± 0.26 microns – mean comet tail length]; [2.69 + 0.19% – % Tail DNA], 
respectively. The results demonstrated that potassium dichromate was highly cytotoxic to 
HepG2 cells, and its cytotoxicity seems to be mediated by oxidative stress and DNA 
damage.  
Keywords: HepG2 cells, cytotoxicity, DNA damage, lipid peroxidation, malondialdehyde, 
potassium dichromate. 
 
 
1. Introduction 
 
Chromium (Cr) is a naturally occurring heavy metal commonly found in the environment in two 
valence states: trivalent Cr (III) and hexavalent Cr (VI). It is widely used in numerous industrial 
processes and as a result, is a contaminant of many environmental systems [1]. Commercial chromium 
compounds are used in industrial welding, metal finishes, leather tanning and wood preservation and it 
is a non-negligible pollutant in the world [2,3]. Studies in animal models also found many harmful 
effects of Cr (VI) on mammals. Subcutaneous administration of Cr (VI) to rats caused severe 
progressive proteinuria, urea nitrogen and creatinine, as well as elevation in serum alanine 
aminotransferase activity and hepatic lipid peroxide formation [4]. Similar studies reported by 
Gumbleton and Nicholls [5] found that Cr (VI) induced renal damage in rats when administered by 
single sc injections. Bagchi et al. demonstrated that in rats Cr (VI) received orally in water induced 
hepatic mitochondrial and microsomal lipid peroxidation, as well as enhanced excretion of urinary 
lipid metabolites including malondialdehyde [6,7]. Moreover, some adverse health effects induced by 
Cr (VI) have been reported in humans. Reports of epidemiological investigations have shown that 
respiratory cancers have been found in workers occupationally exposed to Cr (VI) compounds [8,9]. 
DNA strand breaks in peripheral lymphocytes and lipid peroxidation products in urine observed in 
chromium exposed workers in many researches also showed evidence of the Cr (VI)-induced toxicity 
to humans [10,11]. 
The carcinogenicity of specific chromium compounds is influenced by both the valence and the 
solubility of the chromium species. Chromium (VI) compounds have been reported to be more toxic 
and carcinogenic than chromium (III) ones [12,13] because the former can pass through cell 
membranes more easily than the latter [14]. Once inside the cell, Cr (VI) is reduced to its lower 
oxidation states [Cr (V)] and [Cr (IV)] and then Cr (III) by low molecular weight molecules, 
enzymatic and non-enzymatic reductants [15]. These reactive chromium intermediates are capable of 
generating a whole spectrum of reactive oxygen species (ROS), which is an important characteristic of 
Cr (VI) metabolism [16]. Excessive quantities of ROS generated by these reactions can cause injury to 
cellular proteins, lipids and DNA leading to a state known as oxidative stress [17]. Therefore, one of Int. J. Environ. Res. Public Health 2009, 6          
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the most important damages caused by extraneous Cr (VI) is massive production of ROS during the 
reduction of Cr (VI) in the cell. 
Lipid peroxidation (LPO), the oxidative catabolism of polyunsaturated fatty acids, is widely 
accepted as a general mechanism for cellular injury and death [18,19]. LPO and free radical generation 
are complex and deleterious processes that are closely related to toxicity [20]. LPO has been 
implicated in diverse pathological conditions, including atherosclerosis [21], aging [22], rheumatoid 
arthritis [23], and cancer [24]. It is also involved in the toxicity of pesticides [25], solvents [26] and 
metals [27]. The extension of the oxidative catabolism of lipid membranes can be evaluated by several 
endpoints, but the most widely used method is the quantification of malondialdehyde (MDA), one of 
the stable aldehydic products of lipoperoxidation, present in biological samples [28,29]. 
Although chromium and chromium-containing compounds has been the subject of important 
toxicology research, there exists a lack of appropriate in vitro model to understand the mechanism for 
cytotoxic effects, oxidative stress, and DNA damage. There is also scarcity of scientific data with 
respect to their toxicity in in vitro systems. Therefore, the present work was undertaken to study the 
role of cell proliferation, oxidative stress and DNA damage in HepG2 cells exposed to hexavalent 
chromium. 
 
2. Materials and Methods 
 
2.1. Chemicals 
 
Potassium dichromate, sodium chloride, sucrose, Triton
® X-100, hydrochloric acid, histopaque-
1077, NaOH, ethanol, trypan-blue and EDTA were obtained from Sigma-Aldrich (St. Louis, MO, 
USA). They were of analytical grade or highest grade available. The Lipid Peroxidation (LPO) assay 
kit was purchased from Calbiochem (San Diego, CA, USA). Dulbecco’s Modified Eagle’s Minimal 
Essential Medium (DMEM), Phosphate buffer (pH 7.4), trypsin-EDTA, penicillin, streptomycin, fetal 
bovine serum (FBS) were obtained from GIBCO (New York, NY, USA). Comet assay kit was 
purchased from Trevigen, Inc., (Gaithersburg, MD). Human liver carcinoma, HepG2 cells were 
purchased from ATCC (Manassas, VA). Sterile Tissue culture flask and sterile glass pippets were 
purchased from Fischer-Scientific. 
 
2.2. Cell Culture and Cytotoxicity 
 
Parental HepG2 cells stored in liquid nitrogen were thawed by gentle agitation of their containers 
(vials) for 2 min in a water bath at 37 °C. After thawing, the content of each vial was transferred to a 
75 cm
2 surface area, tissue culture flask, diluted with DMEM supplemented with 10% fetal bovine 
serum (FBS) and 1% streptomycin and penicillin. Then the cells are incubated for 24 h at 37 °C in a 
5% CO2 incubator to allow the cells to grow, and form a monolayer in the flask. Cells grown to 80-
95% confluency were washed with phosphate buffer saline (PBS), trypsinized with 3 mL of 0.25% (v) 
trypsin-0.03%/v) EDTA, diluted, counted and seeded (5 x 10
5 cells/well) in two sets of 96-well 
microtiter tissue culture plates. Int. J. Environ. Res. Public Health 2009, 6          
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Seeded plates were incubated for 24 h at 37 °C in a 5% CO2 incubator. The old medium was 
replaced by 180 µL of fresh medium. Twenty micro liters of serial dilutions of potassium dichromate 
(0, 3.125, 6.25, 12.5, 25 and 50 µM) were added column wise to the 96-well microtiter tissue culture 
plates and incubated for 24 and 48 h exposure time. Cell viability assay was performed using the MTT 
{3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide} method. The absorbance was read at 
a wavelength of 550 nm using microtiter plate reader (Bio-Tek Instruments Inc.). 
 
2.3. ROS Detection 
 
ROS production was quantified by the DCFH-DA method [30] based on the ROS-dependent 
oxidation of DCFH-DA to DCF. An aliquot of cell suspension from each of the four treated and the 
control was centrifuged at 1000x g for 10 min (4 °C). The supernatants were re-centrifuged at 20,000x 
g for 20 min at 4 °C, and then the pellet was re-suspended. The DCFH-DA solution with the final 
concentration of 50 μM and re-suspension were incubated for 30 min at 37 °C. Fluorescence of the 
samples was monitored at an excitation wavelength of 485 nm and an emission wavelength of 538 nm. 
 
2.4. Comet Assay 
 
DNA damage was determined in HepG2 cells exposed to four doses of potassium dichromate and 
control for 48 h using comet assay kit from Trevigen (Gaithersburg, MD). Following isolation the cells 
were mixed with 0.4% Trypan blue solution, after 15-20 min cells were counted and checked for 
viability. The remaining cells were immediately used for single-cell gel electrophoresis. The assay was 
performed according to Singh et al. [31] with slight modifications. All the steps were conducted under 
yellow lamp in the dark to prevent additional DNA damage. Stained Slides are viewed under 
automated robotic epiflorescent microscope. A total of 150 individual cells were screened/sample 
[duplicate, each with 75 cells. Slides were read using DNA damage analysis software [Loats 
Associates Inc., Westminster, MD]. Each experiment was performed in triplicate. Cells with damaged 
DNA displayed high migration of DNA fragments from the nucleus, forming a tail in comet form. 
Most important parameters besides mean comet tail length that were used for analyzing genotoxicity in 
the comet assay were:  
DNA head (DNAH), sum of intensities of all points of the head. 
DNA tail (DNAT), sum of intensities of all points of the tail. 
Percent tail DNA (%DNAT) = 100DNAT/(DNAH+DNAT) 
   
2.5. Malondialdehyde (MDA) Determination 
 
Malondialdehyde concentration was measured in HepG2 exposed to four doses of potassium 
dichromate and a control for 48 h using lipid peroxidation assay kit from Calbiochem (San Diego, CA, 
USA). Briefly, 0.65 mL of 10.3 mM N-methyl-2-phenylindole in acetonitrile was added to 0.2 mL of 
sample. After vortexing for 3-4 sec and adding 0.15 mL of 37% HCl, samples were mixed well and 
closed with a tight stopper and incubated at 45° C for 60 mins. The samples were then cooled on ice, 
centrifuged and the absorbance was measured spectrophotometrically at 586 nm. A calibration curve Int. J. Environ. Res. Public Health 2009, 6          
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of an accurately prepared standard MDA solution (from 2-20 nmol/mL) was also run for 
quantification. Measurements of each group were performed in triplicate. The standard deviations were 
less than ± 10%. 
 
3. Data Analysis and Statistics 
 
Data were compared by ANOVA. Statistical analysis was performed using SAS for Windows 2003 
package program. Using the Dunnett test, multiple comparisons were performed. All values were 
reported as means ± SD for all the experiments. The significance level was set at p<0.05. 
 
4. Results 
 
4.1. Cytotoxicity Assay 
 
The MTT result of the cytotoxic effect of potassium dichromate on human liver carcinoma cells 
following 24 and 48 h of exposure is shown in Figure 1. This figure indicates a strong dose- and time-
dependent response relationship with respect to chromium toxicity. After 48 h of exposure, the 
percentages of cell viability were 100 ± 0.0, 82.0 ± 12.0, 55.0 ± 5.8, 40.0 ± 12.0, and 35.0 ± 3.7% for 
the control, 3.12, 6.25, 12.5 and 25 µM of potassium dichromate respectively. The dose of potassium 
dichromate required to produce 50% reduction in the viability of HepG2 cells (LD50s) were compound 
to be 8.83 ± 3.5 and 6.76 ± 0.7 µg/mL upon 24 and 48 h of exposure, respectively; indicating a dose- 
and time-dependent response with regard to the cytotoxic effect of potassium dichromate.  
 
Figure 1. Cytotoxicity after 24 and 48 h exposure to potassium dichromate in HepG2 cells 
using MTT assay. Each experiment was done in triplicate. Data were represented as means 
± SDs. Statistical significance was indicated as (*) for (p< 0.05). 
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4.2. ROS Detection 
 
ROS were determined in control and exposed groups after administration of potassium dichromate 
to HepG2 for 48 h. The exposure of Cr (VI) to HepG2 cells significantly enhanced the ROS level at 
four tested doses as compared to the control group and increases were found to show dose-dependent 
relationship. Figure2. Represent the result of ROS detection. 
 
Figure 2. Potassium dichromate induced ROS in HepG2 cells. Each experiment was done 
in triplicate. Data were represented as means ± SDs. Statistical significance was indicated 
as (*) for (p< 0.05). 
 
 
4.3. DNA Damage [Comet assay] 
 
Comet tail length is an important parameter in evaluating the DNA damage. All the doses of 
potassium dichromate induced statistically significant increase in mean comet tail length [3.16 ± 0.7 – 
24.8 ± 1.86 microns] indicating DNA damage when compared with controls [3.07±0.26 microns]. 
Maximum increase in mean comet tail length was observed at 25 µM at 48h post-treatment [24.8 
microns]. Besides the mean comet tail length, percent tail DNA was also measured in the exposed and 
control cells. The following percent tail DNA 12.4 ± 1.45%, 19.2 ± 1.16%, 32.6 ± 5.79 and 76 ± 
1.49% respectively was observed in the HepG2 cells exposed to various concentration of potassium 
dichromate compared to control 2.69 ± 0.19%. The mean comet tail length showed a clear dose-
dependent increase from 3.12 to 25 µM. The results of DNA damage cells are illustrated in Figure 
3(A) (B) and (C) respectively. Representative comet assay images of control (A) and potassium 
dichromate treated HepG2 c e l l s  a t  3. 1 2 µ M  ( B ) ;  6. 2 5 µ M  ( C ); 12.5 µM (D) and 25 µM (E) are 
presented in Figure3A. Genotoxicity as characteristized by the length of the comet tail is illustrated in 
Figure 3B. 
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Figure 3. (A) Single Cell Gel Electrophoresis assessment of potassium dichromate toxicity 
in human liver carcinoma cells (HepG2): A) Representative Comet images of control (A), 
and 3.12 µM (B); 6.25 µM (C); 12.5 µM (D) and 25 µM (E); 3(B): Effect of various doses 
of potassium dichromate and control on DNA migration in HepG2 cells at 48 h exposure; 
3(C): Effect of various doses of potassium dichromate and control on the percent tail DNA. 
Each experiment was done in triplicate. Data were represented as means ±SDs. Statistical 
significance was indicated as (*) for (p< 0.05). 
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4.4. Lipid Peroxidation  
 
One of the methods for evaluating lipid peroxidation is measurement of malondialdehyde 
concentration in the cells. Potassium dichromate exposure significantly (p<0.05) increased the 
concentration of MDA in HepG2 cells when compared with the control. Results are illustrated in 
Figure 4. The increase in MDA concentration in HepG2 was found to be dose-dependent, indicating a 
gradual increase with increasing dose of potassium dichromate. Statistically significant increase in the 
concentration of malondialdehyde [MDA], an indicator of lipid peroxidation, was recorded in exposed 
cells [15.9 – 69.9 µM] compared to control [13 µM]. 
Figure 4. Induction of lipid peroxidation in HepG2 cells by various doses of potassium 
dichromate and control. Each experiment was done in triplicate. Data were represented as 
mean + SD. Statistical significance was indicted as (*) for (p <0.05). 
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5. Discussion 
 
In the present study concentration- and time-dependent effects of potassium dichromate were 
assessed on the reductions of tetrazolium dye MTT in cultured HepG2 cells. This is a marker of 
succinate dehydrogenase activity, an index of the mitochondrial electron transport system, which is 
used to assess cell viability. Only viable cells with intact mitochondria can reduce tetrazolium dye 
MTT and the amount of MTT reduced is directly proportional to the number of viable cells present. 
Data obtained from the present study, clearly indicate that potassium dichromate is highly cytotoxic to 
human liver carcinoma cells. The LD50 were computated to be 8.83 ± 3.5 and 6.76 ± 0.7 µg/mL after 
24 and 48 h of exposure, respectively; indicating a dose- and time-dependent response with regards to 
the cytotoxic effect of potassium dichromate. These results support those of a previous investigation 
reporting a marked reduction in the viability of K562 and J774 cells exposed to chromium (VI) [32]. 
In this study we observed that there was a significant increase in the level of ROS in HepG2 cells 
exposed to potassium dichromate compared to control. Reactive oxygen species (ROS) have been 
implicated in the toxicity of chromium (VI) by several authors [7,15,33]. Their formation with 
subsequent cellular damage is considered as the common molecular mechanism of Cr (VI)-induced 
toxicity. According to this hypothesis, chromium (VI) itself is not a cytotoxic agent but rather an 
oxygen free radical generator through cellular reduction to chromium (VI) [34]. Chromium reduction 
intermediates are believed to react with hydrogen peroxide to form the hydroxyl radical [35], which Int. J. Environ. Res. Public Health 2009, 6          
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may finally attack proteins, DNA, and membranes lipids thereby disrupting cellular functions and 
integrity [7]. 
In the present study, measuring the concentration of MDA in HepG2 of potassium dichromate-
exposed and control group assessed lipid peroxidation. There was a significant increase in the 
concentration of MDA after 48 h of potassium dichromate administration. These results are in 
accordance with those obtained by Bagchi et al. [32], who detected oxidative lipid metabolites in K562 
and J774 cells exposed to Cr (VI). The increase observed in lipid peroxidation may be due to the 
formation of hydroxyl radical (HO) through a Fenton/Haber-Weiss reaction, catalysed by chromium. 
This radical is capable of abstracting a hydrogen atom from a methylene group of polyunsaturated 
fatty acids enhancing lipid peroxidation.  
The frequency of single-strand breaks showed a clear dose-related increase in HepG2 cells up to 25 
µM in our investigation. Maximum DNA damage was observed at 48 h post-treatment when compared 
with the controls. Similar results were reported with other heavy metals in rodents and in other cell-
lines using comet assay [3,36]. Cr (VI) itself is not reactive to DNA, however, the chromium 
metabolites radicals produced during reduction can subsequently attack macromolecules and lead to 
multiform DNA damages e.g. strand breakage, DNA-protein cross-links, DNA-DNA cross-links, Cr-
DNA adducts and base modifications in cells. Especially DNA strand breaks are mainly ascribed to the 
ROS [3,37,38]. Single cell gel electrophoresis (comet assay) is a highly sensitive technique to evaluate 
single strand breaks and alkali labile sites in DNA of individual cells. 
In summary, the current study demonstrates that administration of Cr (VI) to human liver carcinoma 
cells for 48 h could induce cytotoxicity, DNA damage and oxidative stress. ROS may play an essential 
role in DNA damage and oxidative stress induced by Cr (VI) in vitro. Our results show that the use of 
thiobarbituric acid reactive substances (TBARS) as a marker of oxidative stress should be 
complemented with antioxidant parameters namely SOD and CAT. The results support an involvement 
of the oxidative damage pathway in the mechanism of toxicity of chromium. Further studies of the 
behavior of the antioxidant enzymes can aid in the understanding of chromium-induced toxicity. 
 
Acknowledgements 
 
This research was financially supported by a grant from the National Institutes of Health - (Grant 
No 1G12RR13459), through the RCMI-Center for Environmental Health at Jackson State University. . 
The authors thank Dr. Abdul K. Mohamed, Dean Emeritus, and the RCMI external advisory 
committee members, for their technical support in this project. 
 
References 
 
1.  Cohen, M.D.; Kargacin, B.; Klein, C.B.; Costa, M. Mechanisms of chromium carcinogenicity and 
toxicity. Crit. Rev. Toxicol. 1993, 23, 255-281. 
2.  Norseth, T. The carcinogenicity of chromium - Review. Environ. Health. Perspect. 1981, 40, 121-
30. 
3.  Wang, X.F.; Xing, M.L.; Shen, Y.; Zhu, X.; Xu, L.H. Oral administration of Cr (VI) induced 
oxidative stress, DNA damage and apoptotic cell death in mice. Toxicology. 2006, 228, 16-23. Int. J. Environ. Res. Public Health 2009, 6          
 
652
4.  Kim, E.; Na, K.J. Nephrotoxicity of sodium dichromate depending on the route of administration. 
Arch. Toxicol. 1991, 65, 537-541. 
5.  Gumbleton, M.; Nicholls, P.J. Dose-response and time-response biochemical and histological 
study of potassium dichromate-induced nephrotoxicity in the rat. Food Chem.Toxicol. 1988, 26, 
37-44. 
6.  Bagchi, D.; Hassoun, E.A.; Bagchi, M.; Muldoon, D.; Stohs, S.J. Oxidative stress induced by 
chronic administration of sodium dichromate (Cr VI) to rats. Comp. Biochem. Physiol. 1995a, 
110C, 281-287. 
7.  Bagchi, D.; Vuchetich, P.J.; Bagchi, M.; Hassoun, E.A.; Tran, M.X.; Tang, L.; Stohs, S.J. 
Induction of oxidative stress by chronic administration of sodium dichromate (chromium VI) and 
cadmium chloride (cadmium II) to rats. Free Rad. Biol. Med. 1997b, 22, 471-478. 
8.  Costa, M. Toxicity and carcinogenicity of Cr (VI) in animal models and humans. Crit. Rev. 
Toxico. 1997, 27, 431-42. Review.  
9.  Dayan, A.D.; Paine, A.J. Mechanisms of chromium toxicity, carcinogenicity and allergenicity: 
review of the literature from 1985 to 2000. Hum. Exp. Toxicol. 2001, 20, 439-51. Review.  
10.  Gambelunghe, A.; Piccinini, R.; Ambrogi, M.; Villarini, M.; Moretti, M.; Marchetti, C.; Abbritti, 
G.; Muzi, G. Primary DNA damage in chrome-plating workers. Toxicology 2003, 188, 187-95.  
11.  Goulart, M.; Batoreu, M.C.; Rodrigues, A.S.; Laires, A.; Rueff, J. Lipoperoxidation products and 
thiol antioxidants in chromium exposed workers. Mutagenesis 2005, 20, 311-15.  
12.  Connett, P.H.; Wetterhahn, K.E. Metabolism of carcinogenic chromate by cellular constituents. 
Struct. Bonding 1983, 54, 93-24. 
13.  De Flora, S.; Bagnasco, M.; Serra, D.; Zanacchi, P. Genotoxicity of chromium compounds: a 
review. Mutat. Res. 1990, 238, 99-172.  
14.  De Flora, S.; Wetterhahn, K.E. Mechanisms of chromium metabolism and genotoxicity. Life 
Chem. Rep. 1989, 7, 169-244. 
15.  Shi, X.; Chiu, A.; Chen, C.T.; Halliwell, B.; Castranova, V.; Vallyathan, V. Reduction of 
chromium (VI) and its relationship to carcinogenesis. J. Toxicol. Environ. Health 1999, 2, 87-104. 
16.  O’ Brien, T.J.; Ceryak, S.; Patierno, S.R. Complexities of chromium carcinogenesis: role of 
cellular response, repair and recovery mechanisms. Mutat. Res. 2003, 533, 3-36. 
17.  Nordberg, J.; Arner, E.S. Reactive oxygen species, antioxidants, and the mammalian thioredoxin 
system. Free Radical Biol. Med. 2001, 31, 1287-1312.  
18.  Gutteridge, J.M.C.; Quinlan, G.J. Malondialdehyde formation from lipid peroxides in 
thiobarbituric acid test. The role of lipid radicals, iron salts and metal chelator. J. Appl. Biochem. 
1983, 5, 293-299. 
19.  Halliwell, B. Oxygen radicals: A common sense look at their nature and medical importance. 
Med. Biol. 1984, 62, 71-77. 
20.  Murray, R.K.; Granner, D.K.; Mayes, P.A.; Rodwell, V.W. Harper’s Biochemistry, 21
st Edition; 
Prentice Hall: NJ, USA, 1988; pp. 138-139.  
21.  Holvoet, P.; Collen, D. Oxidation of low density lipoproteins in the pathogenesis of 
atherosclerosis. Atherosclerosis 1998, 137 (Suppl.), S33-S38. 
22.  Spiteller, G. Lipid peroxidation in aging and age-dependent diseases. Exp. Gerontol. 2001, 36, 
1425-1457. Int. J. Environ. Res. Public Health 2009, 6          
 
653
23.  Henrotin, Y.; Deby-Dupont, G.; Deby, C.; Franchimont, P.; Emerit, I. Active oxygen species, 
articular inflammation and cartilage damage. EXS 1992, 62, 308-322. 
24.  Marnett, L.J. Oxyradicals and DNA damage. Carcinogenesis 2000, 21, 361-370. 
25.  Bismuth, C.; Garnier, R.; Baud, F.J.; Muszynski, J.; Keyes, C. Paraquat poisoning; An overview 
of current status. Drug Saf. 1990, 5, 243-251. 
26.  Brattin, W.J.; Glende, E.A.; Recknagel, R.O. Pathological mechanisms in carbon tetrachloride 
hepatotoxicity. J. Free Radic. Biol. Med. 1985, 1, 27-38. 
27.  Kasprzak, K.S. Possible role of oxidative damage in metal induced carcinogensis. Cancer Inv. 
1995, 13, 411-430. 
28.  De Zwart, L.L.; Meerman, J.H.; Commandeur, J.N.; Vermeulen, N.P. Biomarkers of free radical 
damage applications in experimental animals and in humans. Free Radic. Biol. Med. 1999, 26, 
202-226. Review.  
29.  Gutteridge, J.M.C. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin. 
Chem. 1995, 41, 1819-1828. 
30.  Lawler, J.M.; Song, W.; Demaree, S.R. Hindlimb unloading increases oxidative stress and 
disrupts antioxidant capacity in skeletal muscle. Free Radical. Biol. Med. 2003, 35, 9-16. 
31.  Singh, N.P.; McCoy, M.T.; Tice, R.R.; Schneider, E.L. A simple technique for quantitation of low 
levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175, 184-191. 
32.  Bagchi, D.; Bagchi, M.; Stohl, S.J. Chromium (VI)-induced oxidative stress, apoptotic cell death 
and modulation of p53 tumor suppressor gene. Mol. Cell Biochem. 2001, 222, 149-158. 
33.  Sugiyama, M. Role of physiological antioxidants in Cr (VI) induced cellular injury. Free Rad. 
Biol. Med. 1992, 12, 397-407. 
34.  Miesel, R.; Kroger, H.; Kurpisz, M.; Wesser, U. Induction of arthritis in mice and rats by 
potassium peroxochromate and assessment of disease activity by whole blood chemiluminescence 
and 99mpertechnetate-imaging. Free Radic. Res. 1995, 23, 213-227. 
35.  Kadiiska, M.B.; Xiang, Q.H.; Mason, R.P. In vivo free radical generation by chromium (VI): An 
electron-spin resonance spin-trapping investigation. Chem. Res. Toxicol. 1994, 7, 800-805.  
36.  Dana Devi, K.; Rozati, R.; Saleha Banu, B.; Jamil, K.; Grover, P. In vivo genotoxic effect of 
potassium dichromate in mice leukocytes using comet assay. Food Chem. Toxicol. 2001, 39, 859-
865. 
37.  Wise, S.S.; Holmes, A.L.; Wise, J.P. Sr. Hexavalent chromium-induced DNA damage and repair 
mechanisms. Rev Environ Health. 2008, 23, 39-57. 
38.    Blasiak, J.; Kowalik, J. A comparison of the in vitro genotoxicity of tri and hexavalent 
chromium. Mutat Res. 2000, 469, 135-145. 
 
© 2009 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. 
This article is an open-access article distributed under the terms and conditions of the Creative 
Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). 